Sentences with phrase «environment than any other technology»

The European Academies Science Advisory Council concurred, stating there «is no validated evidence that GM crops have greater adverse impact on health and the environment than any other technology used in plant breeding».

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Your main obligation is to cover the 8 Key learning Areas (KLAs)- science, maths, English, the arts, studies of society and environment, technology, language other than English and health and physical education.

► This week's issue of Science also includes a brief recap of the 40th annual AAAS Forum on Science and Technology Policy, attended by «more than 400 elected officials, government and business leaders, researchers, educators, and others» on 30 April and 1 May in Washington, D.C. «The importance of basic research for the nation's scientific and economic future was a recurring theme,» and «participants delved into the factors driving the tight budget environment» scientists are currently facing.

Although many other developments and technologies have come along to help us reproduce almost like rabbits, Laland argues that «if it were the case that humans were adapted to environments in the Pleistocene [epoch ending more than 10,000 years ago] but not the Holocene [modern era, which followed], you would expect human populations would have shrunk when they moved into urban environments.»

Some of these technologies are less noticeable than others like they are with the iPad Air 2 and original iPad Air but the True Tone technology is great, adapting the colour and intensity of the display to match the light in your environment.

«The consistent growth of e-books demonstrates that publishers have successfully evolved the technology environment for their content — more so than other historically print - based content industries.

It tries to explain why things happened the way they did; why certain societies developed agriculture and certain technologies earlier than others (the local environment and climate plays a big role), etc..